期刊文献+

应用外周静脉留置针输入奥沙利铂的临床观察 被引量:2

Clinical Observation of Infusion of Oxaliplatin by Peripheral Intravenous Detaining Needle
下载PDF
导出
摘要 目的:观察外周静脉留置针输入奥沙利铂的外渗率。方法:104例胃肠道恶性肿瘤患者进行含奥沙利铂方案化疗,共完成592个周期。观察组用外周静脉留置针输入奥沙利铂480人次,对照组采用钢针输入奥沙利铂112人次,记录两种方法输入奥沙利铂的外渗情况。结果:用外周静脉留置针输入奥沙利铂外渗率为1.04%,钢针输入奥沙利铂的外渗率为21.43%,差异有统计学意义(P=0.000)。结论:应用外周静脉留置针输入奥沙利铂外渗率低,并且经济、安全、实用,值得临床推广应用。 Objective: To observe the exosmosls rate of intravenous infusion of oxaliplatin by peripheral intravenous detaining needle. Methods: 104 cases of gastrointestinal cancer accepted a total of 592 cycles of chemotherapy which containing oxaliplatin. The peripheral intravenous detaining needle was used in the observation group to infuse oxallplatin for total of 480 person-time while the needle was used in the control group for 112 person-time. Exosmosis rate was recorded in two groups. Results : The exosmosis rate was 1.04% and 21.43% in observation group and control group respectively. The difference was statistically significant (P = 0. 000). Conclusion: The application of peripheral intravenous detaining needle to infuse oxaliplatin gets low exosmosis rate. It is an economical , safe, practical way of infusion and worthy of clinical application.
作者 袁碧芳
出处 《肿瘤预防与治疗》 2011年第2期110-112,共3页 Journal of Cancer Control And Treatment
关键词 外周静脉留置针 钢针 奥沙利铂 外渗率 Peripheral Intravenous Detaining Needle Needle Oxaliplatin Exosmosis Rate
  • 相关文献

参考文献6

二级参考文献22

  • 1The Meta-analysisGroup in Cancer:Efficacy intravenous continuous infusion of fluorouracil compared withbolus administration in advanced colorectal cancer[J].J Clin Oncol,1998,16(2):301-303.
  • 2小西敏郎,野家环,阿部哲夫,他.Methotrexateにょる5-fluorouracilの效果增强[J].癌と化学疗法,1999,26(4):431-439.
  • 3岩本末治,木元正利,牟礼勉.进行胃癌MTX/5-FU交代疗法の效果とその问题点[J].癌と化学疗法,1998,25(6):541-544.
  • 4小西敏郎.食道癌*胃癌[J].癌と化学疗法,1999,26(6):118-122.
  • 5佐佐木常雄 前田义治 小林健彦.消化器癌Leucovorin.5—FU并用疗法[J].癌と化学疗法,1999,26(4):440-446.
  • 6De Gramont,A,Bosset JF,Milan C,et al.Randomized trial comparing monthly low doseleucovorin and fluorouracil bolus with bi-monthly high dose leucovorin and fluorouracilbolus continuous infusion for advanced colorectal cancer[J].J ClinOncol,1997,15(2):808-812.
  • 7佐佐木常雄 前田义治 王哲海.切除不能、再发胃癌の化学疗法[J].消化器外科,1998,21(7):1317-1322.
  • 8Jager E,Heike M,Bernhard H,et al.Weekly high-dose leucovorin combined withfluorouracil in advanced colorectal cancer:results of a randomized multicentre trial.StudyGroup of Palliative Treatment of Metastatic colorectal cancer study protocol 1[J].JClin Oncol,1996,14(8):2247-2249.
  • 9GIVIO-SITAC 01:A randomized trial of adjuvant 5-flouorouracil and folinic acidadministered to patients with colon carcinoma-long term results and evaluation of theindicators of health-related quality of life[J].Cancer,1998,82(5):2135-2138.
  • 10Tepper JE,O'Connell MJ,Petroni,GR,et al.Adjuvant postoperativefluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectalcancer:Initial results of inter group 0114[J].J Clin Oncol,1997,15(2):2030-2033.

共引文献464

同被引文献5

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部